"AI-accelerated research to define aging in the brain, enabling personalized therapies and faster market delivery for aging populations"
Errungenschaften
Team
Prototyp
Nutzer
Partner
Umsätze
Investoren
Unser Angebot
- New biomarkers and therapeutics for aging and psychiatric disorders.
- Diagnostics and drug candidates targeting glial cells.
- AI-powered research for personalized aging therapies.
- Strategic partnerships and IP licensing to the pharmaceutical industry.
- Diagnostic pipeline for stratifying aging and predicting clinical outcomes.
Zielgruppe
- Pharmaceutical companies
- Clinical research organizations
- Healthcare providers specializing in aging and neurodegenerative diseases
- Investors in biotech and AI-driven medical solutions
- Collaborative research partners in the medical and biotech fields
Herausforderungen
- Securing funding and investment.
- Building and maintaining strategic partnerships.
- Regulatory approvals for new diagnostics and therapeutics.
- Scaling operations efficiently.
- Protecting intellectual property and managing legal issues.
Unsere Story
Hauptsitz
Weitere Startups
Diese Gründungsprojekte könnten auch interessant für Dich sein!
